Previous 10 | Next 10 |
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investor...
Following a ~54.7% rise today, Neovasc (NVCN) is continuing the momentum into after-hours trading with a gain of ~45.9% on the news of a patent win in Europe.The company has received a decision to grant European patent number EP3400907 titled "sequentially deployed tr...
Neovasc (NVCN) traded 3.3% higher premarket after receiving written notification from the Nasdaq that it has regained compliance with the minimum bid price requirement.Currently, the company is still not in compliance with the minimum market value requirement.Nasdaq Listin...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 9, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received written notification from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that...
VANCOUVER and MINNEAPOLIS, Feb. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc , Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN) today announced that the Journal of the American Heart Association has published an article entitled, “Angina Seve...
VANCOUVER and MINNEAPOLIS, MN, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the German Institute for the Hospital Remuneration System("InEK") has awarded the Neovasc Reducer&...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - January 29, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT®) Category...
VANCOUVER and MINNEAPOLIS, MN, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc . (“Neovasc” or the “Company”) ( Nasdaq , TSX : NVCN) announced today the Neovasc Reducer™ (“Reducer”) was prominently fe...
ProPhase Labs (PRPH) -23% after pricing equity offering.Neovasc (NVCN) -18%.Biohaven Pharmaceutical (BHVN) -13%.Yield10 Bioscience (YTEN) -12%.Technical Communications (TCCO) -10% after receiving delisting notice from Nasdaq.InVivo Therapeutics (NVIV) -8%.Lumentum Holdings (LIT...
Neovasc (NVCN) is trading ~18.3% lower in post-market hours after the company announced the receipt of a 'not-approvable' letter from the FDA regarding its PMA (premarket approval) submission for the Neovasc Reducer™.The FDA reviewed Reducer for treating patients with refract...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...